More older women with breast cancer may not need radiation therapy, and supply shortages hinder bladder cancer treatment.

by Kevin McLaughlin

Patients who receive certain forms of chemo face long-term risk for heart failure, and screening levels for certain cancers remain below expectations.

by Thomas Celona

Group says more women should consider removing fallopian tubes to lower ovarian cancer risk, and treatment guidelines can lead to arbitrary age cutoffs.

by Eric Fitzsimmons

Many women underestimate dense breast effect on cancer risk, and FDA approves targeted therapy for colorectal cancer.

by Kevin McLaughlin

Women experience faster decline in physical function after cancer, and treatment quality for lung cancer varies across the US.

by Marci A. Landsmann

Women over 65 diagnosed at later stages of cervical cancer, and Black and Hispanic patients prescribed fewer opioids for end-of-life cancer care.

by Eric Fitzsimmons

Cancer patients have an increased risk of breakthrough COVID-19 infections, and CAR T-cell therapy is safe for lymphoma patients with HIV.

by Thomas Celona

A second KRAS inhibitor is approved for lung cancer, and a BTK inhibitor challenges standard of care for relapsed or refractory CLL.

by Marci A. Landsmann

Medical marijuana used as a substitute for opioids, and chemo and endocrine therapy together increase cancer-related cognitive impairment.

by Kevin McLaughlin

Oncologists report that prior authorization process interrupts cancer care, and plant-based diet is associated with lower colorectal cancer risk in men but not women.

by Eric Fitzsimmons